mJOA Scale in Physical Therapy: An Infographic

The Modified Japanese Orthopedic Assessment (mJOA) Scale

A Physical Therapist's Guide to Understanding and Utilizing the mJOA for Cervical Myelopathy

Max Score: 18 Points

The mJOA is a crucial clinician-administered tool for evaluating functional impairment in patients with cervical myelopathy, particularly Degenerative Cervical Myelopathy (DCM). It provides a standardized score from 0 (most severe) to 18 (no dysfunction).

What is the mJOA?

Purpose & Target Population

The mJOA quantifies neurological status by assessing motor deficits (upper/lower extremities), upper extremity sensory disturbances, and bladder dysfunction due to cervical spinal cord compression. It's primarily used for adult patients with Degenerative Cervical Myelopathy (DCM), also known as Cervical Spondylotic Myelopathy (CSM).

Its functions include grading disease severity, guiding treatment decisions (surgical vs. non-surgical), and monitoring patient outcomes over time.

Evolution: From JOA to mJOA

The original JOA scale had culturally specific tasks. The mJOA (notably the Benzel 18-point version) adapted these for broader international use.

🥢

Original JOA (e.g., Chopsticks)

➡️
🥄👔

mJOA (e.g., Spoon, Buttons)

This adaptation made the mJOA more universally applicable, especially in Western populations, enhancing its clinical relevance for physical therapists worldwide.

Decoding the mJOA Score (Benzel 18-Point Version)

Functional Domains Assessed

The mJOA evaluates four key functional domains. A higher score in each domain indicates better function. This infographic focuses on the Benzel 18-point version.

The emphasis on functional tasks like eating, dressing, and walking makes the mJOA directly relevant to physical therapy goals.

Severity Classification

The total mJOA score (0-18) categorizes myelopathy severity, guiding clinical decisions:

  • Mild Myelopathy: Score 15-17
  • Moderate Myelopathy: Score 12-14
  • Severe Myelopathy: Score 0-11

These classifications are crucial for discussions with surgeons and other specialists, aligning with international treatment guidelines.

Administering the mJOA: Key Steps & Scoring

The mJOA is clinician-administered, combining patient interview and direct observation of functional tasks. Consistent application is key for reliable results. This section outlines the general process and detailed scoring for the Benzel 18-point version.

  1. Preparation & Setup:
    • Gather basic patient demographic and clinical information.
    • Have the mJOA scoring sheet and instructions readily available.
    • Ensure a suitable environment for observation if needed.
  2. Domain-by-Domain Assessment & Scoring: Systematically evaluate and score each of the four functional domains:
    • I. Upper Extremity Motor Function (Max Score: 5)

      Assesses hand dexterity and ability to perform common ADLs.

      • 5 points: No dysfunction.
      • 4 points: Able to button shirt with slight difficulty.
      • 3 points: Able to button shirt with great difficulty.
      • 2 points: Inability to button shirt but able to eat with a spoon.
      • 1 point: Inability to eat with a spoon but able to move hands.
      • 0 points: Inability to move hands.
    • II. Lower Extremity Motor Function (Max Score: 7)

      Evaluates walking capability, balance, need for walking aids, and ability to navigate stairs.

      • 7 points: No dysfunction.
      • 6 points: Mild disturbance of gait; able to walk unaided with smooth reciprocation; >30% of time spent on one leg during single stance phase is possible.
      • 5 points: Moderate to marked disturbance of gait but able to walk unaided; >30% of time spent on one leg during single stance phase is not possible.
      • 4 points: Able to walk up and/or down stairs with handrail.
      • 3 points: Able to walk on flat floor with walking aid (cane or walker).
      • 2 points: Able to move legs but unable to walk.
      • 1 point: Sensory preservation without ability to move legs.
      • 0 points: Complete loss of motor and sensory function.
    • III. Upper Extremity Sensory Function (Max Score: 3)

      Inquires about the presence and severity of sensory deficits (numbness, tingling, pain) in the hands.

      • 3 points: No sensory loss.
      • 2 points: Mild sensory loss.
      • 1 point: Severe sensory loss or pain.
      • 0 points: Complete loss of hand sensation.
    • IV. Sphincter (Bladder) Function (Max Score: 3)

      Assesses degree of difficulty with micturition and urinary continence.

      • 3 points: Normal micturition.
      • 2 points: Mild to moderate difficulty with micturition.
      • 1 point: Marked difficulty with micturition.
      • 0 points: Inability to urinate voluntarily.
  3. Assign Scores: For each item within the domains, select and record the score that best reflects the patient's current functional level according to the specific criteria for that item.
  4. Calculate Total Score: Sum the scores from all four domains to obtain the total mJOA score. The maximum possible score is 18.
  5. Classify Severity: Use the total mJOA score to classify the severity of myelopathy: Mild (15-17), Moderate (12-14), or Severe (0-11).

Best Practices for Administration:

  • Employ consistent questioning techniques for all patients.
  • Provide clear and simple instructions to the patient.
  • Maintain objective observation standards when assessing functional tasks.
  • Formal training in mJOA administration is highly recommended to enhance inter-rater reliability and ensure accurate scoring.

Why mJOA Matters for Physical Therapists

Guiding Treatment Decisions in DCM

mJOA scores are integral to AO Spine and other international guidelines for DCM management. Physical therapists can use this to understand appropriate care pathways.

Patient with Suspected DCM: Assess mJOA Score
⬇️

Severe DCM (mJOA 0-11)

⬇️
Surgery Strongly Recommended

PT: Pre-hab, education, post-op recovery.

Moderate DCM (mJOA 12-14)

⬇️
Surgery Strongly Recommended

PT: Pre-hab, education, post-op recovery.

Mild DCM (mJOA 15-17)

⬇️
Offer Surgery OR Supervised PT Trial

PT: Key role in conservative care & monitoring.

This framework helps physical therapists in shared decision-making and appropriate patient referral.

Tracking Progress: The MCID

The Minimal Clinically Important Difference (MCID) is the smallest score change patients perceive as beneficial. For mJOA, it Varies by Baseline Severity:

Physical therapists MUST use the severity-specific MCID for accurate goal setting and judging intervention effectiveness. A 1-point change for severe DCM is different from a 1-point change for mild DCM.

Informing PT Assessment & Goal Setting

The mJOA helps PTs to:

  • Classify severity: Understand the patient's current functional status.
  • Identify specific deficits: Subscores (UE/LE motor, UE sensory, sphincter) pinpoint areas for targeted PT interventions (e.g., gait, hand dexterity).
  • Set realistic goals: Use the baseline mJOA and appropriate MCID to establish meaningful short-term and long-term functional goals.
  • Educate patients: Explain scores in functional terms to improve engagement.
  • Inform referrals: A low mJOA, especially with red flags (e.g. Babinski sign), warrants urgent neurosurgical consultation.

mJOA in PT Practice: Strengths & Weaknesses

👍 Strengths

  • Standardized measure for myelopathy-related function.
  • Guides treatment decisions & aligns with clinical guidelines.
  • Facilitates interdisciplinary communication.
  • Useful for tracking progress (with correct MCID use).
  • Valuable tool for patient education.
  • Subscores direct targeted PT interventions.

👎 Weaknesses & Challenges

  • Some subjectivity; inter-rater reliability varies for certain subscores (e.g., UE Sensation ICC 0.63).
  • May not be sensitive to very subtle changes.
  • Potential for floor/ceiling effects (esp. sensory, sphincter).
  • Limited scope: Does not fully capture pain, patient-reported disability (NDI), or Quality of Life (SF-36).
  • Administration time in busy clinics.
  • Requires training for consistent application.
  • Early detection use in PT needs more research.

Understanding these aspects allows PTs to use the mJOA effectively as part of a comprehensive assessment, complementing it with other measures like the NDI or PROMIS PF for a holistic view.

mJOA in the Assessment Toolbox

The mJOA provides unique information but is best used alongside other tools. Here's a conceptual look at how it relates to other common measures:

mJOA
(Functional Impairment)
NDI
(Pain/Disability)
Nurick
(Gait)

The mJOA is strong for clinician-observed function. PROMs like NDI capture the patient's subjective experience. Tools like Nurick focus on specific aspects like gait. A multi-tool approach is often best.

The Future of mJOA & PT

Ongoing research aims to enhance the mJOA's utility:

📝

Patient-Reported mJOA (P-mJOA)

Validation of P-mJOA could improve efficiency and reduce administrator bias. More research is needed on its equivalence to the clinician-administered version.

🔍

Role in Early DCM Detection

"Flipping the mJOA" for early detection (e.g., score ≤16 or ≤17 as a flag) is promising, especially for PTs in primary contact roles. This requires more research on feasibility and optimal screening cut-offs in PT settings to combat diagnostic delays.

Further research also focuses on enhancing reliability, refining subscales, and establishing comprehensive core outcome sets for DCM that include the mJOA.

Key Takeaway for Physical Therapists

The mJOA scale is an invaluable, internationally recognized tool for physical therapists assessing and managing Degenerative Cervical Myelopathy. A thorough understanding of its structure, scoring (including severity-specific MCIDs), psychometric properties, and appropriate clinical application empowers PTs to improve diagnostic accuracy, tailor effective interventions, and contribute significantly to multidisciplinary patient care.

Always complement mJOA findings with patient-reported outcomes and a comprehensive clinical examination for holistic patient management.

References

The content of this infographic is primarily based on the comprehensive research report titled:

"The Modified Japanese Orthopedic Assessment (mJOA) Scale: Considerations for Physical Therapy Practice"

(Provided as source material for the generation of this infographic).

Specific scoring criteria for the mJOA domains detailed in the "Administering the mJOA: Key Steps & Scoring" section are adapted from Table 1 of the aforementioned report, which synthesizes information from sources including:

  • Benzel EC, Lancon J, Kesterson L, Hadden T. Cervical laminectomy and dentate ligament section for cervical spondylotic myelopathy. *J Spinal Disord*. 1991;4(3):286-295.
  • Chiles III BW, Leonard MA, Kalfas IH, Wilke WS. Local surgeons’ experience with the Japanese Orthopaedic Association score for cervical myelopathy. *Neurosurgery*. 1999;44(1):217-218.
  • Other foundational literature on the mJOA scale.

Note: While this infographic aims for accuracy based on the provided report, users should always consult primary research and clinical guidelines for comprehensive information and decision-making.

Terapia manual moderna: el enfoque ecléctico para el manejo temporomandibular

5.0
$ 399.99
$ 199.99
$ 200.00